| |
| |
|
| Insider
Information: |
Xanthopoulos Kleanthis G |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
122,200 |
|
|
Indirect Shares
|
281,935 |
|
|
| Direct
Value |
$19,622 |
|
|
|
Indirect Value
|
$164,649 |
|
|
| Total
Shares |
404,135 |
|
|
| Total
Value |
$184,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2007-08-16 |
7,399 |
2007-08-16 |
177,144 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
Director |
2012-08-15 |
87,500 |
2017-01-05 |
24,575 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
President and CEO, Dir... |
2015-04-21 |
3,705 |
2015-04-21 |
80,216 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2021-06-10 |
23,596 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANDS |
Anadys Pharmaceuticals In... |
CEO and PresidentOfficer |
• • – |
2004-03-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
244,885 |
|
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEOOfficer |
• • – |
2012-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
82,216 |
|
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-27 |
4 |
AS |
$19.50 |
$1,365 |
D/D |
(70) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-27 |
4 |
OE |
$0.38 |
$27 |
D/D |
70 |
2,536 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-11-14 |
4 |
AS |
$5.00 |
$500 |
I/I |
(100) |
175,644 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-09 |
4 |
AS |
$7.00 |
$735 |
D/D |
(105) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-09 |
4 |
OE |
$0.38 |
$40 |
D/D |
105 |
2,571 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-20 |
4 |
AS |
$7.00 |
$2,100 |
D/D |
(300) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-20 |
4 |
OE |
$0.38 |
$114 |
D/D |
300 |
2,766 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-14 |
4 |
OE |
$0.38 |
$152 |
D/D |
400 |
2,866 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-14 |
4 |
AS |
$7.00 |
$2,800 |
D/D |
(400) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-17 |
4 |
OE |
$0.38 |
$152 |
D/D |
400 |
2,866 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-10-17 |
4 |
AS |
$7.04 |
$2,816 |
D/D |
(400) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-05-28 |
4 |
AS |
$7.00 |
$6,126 |
D/D |
(875) |
0 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-05-28 |
4 |
OE |
$0.38 |
$333 |
D/D |
875 |
875 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-05-29 |
4 |
OE |
$0.38 |
$337 |
D/D |
887 |
887 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-05-29 |
4 |
AS |
$7.00 |
$6,209 |
D/D |
(887) |
0 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-05-27 |
4 |
OE |
$0.38 |
$662 |
D/D |
1,743 |
1,743 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-05-27 |
4 |
AS |
$7.00 |
$12,203 |
D/D |
(1,743) |
0 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2013-12-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
80,216 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-09-30 |
4 |
OE |
$0.38 |
$874 |
D/D |
2,300 |
4,766 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2014-09-30 |
4 |
AS |
$7.02 |
$16,137 |
D/D |
(2,300) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-02 |
4 |
AS |
$19.77 |
$47,440 |
D/D |
(2,400) |
2,466 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President and CEO |
• • – |
2015-02-02 |
4 |
OE |
$0.38 |
$912 |
D/D |
2,400 |
4,866 |
0 |
- |
|
| SEEL |
Seelos Therapeutics Inc |
Director |
– • – |
2013-03-21 |
4 |
AS |
$2.50 |
$7,160 |
I/I |
(2,864) |
81,511 |
0 |
- |
|
89 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
